BiotechTube
Home/OKYO Pharma/Pedram Hamrah
PH

Pedram Hamrah

Member, Scientific Advisory Board

OKYO Pharma

Therapeutic Areas

OphthalmologyPain

OKYO Pharma Pipeline

DrugIndicationPhase
Urcosimod (OK-101)Neuropathic Corneal Pain (NCP)Phase 2

Leadership Team at OKYO Pharma

GC
Gabriele Cerrone
Non-Executive Chairman
RD
Robert Dempsey
Chief Executive Officer/Director
FM
Flavio Mantelli
Chief Medical Officer
JS
Jay S. Pepose
Member, Scientific Advisory Board
VP
Victor Perez
Member, Scientific Advisory Board
AG
Anat Galor
Member, Scientific Advisory Board
MM
Mina Massaro Giordano
Member, Scientific Advisory Board
View full OKYO Pharma profile